Get started
Author

Giulia Galli

Observed names: G Galli, G. Galli, Galli, G., Giulia GALLI
Observed institutions: University of Pisa, National Institutes of Health, Università Campus Bio-Medico, Mario Negri Institute for Pharmacological Research, University of Pavia, Agostino Gemelli University Polyclinic, National Institute of Diabetes and Digestive and Kidney Diseases, Ospedale Maggiore Carlo Alberto Pizzardi, Fondazione Michelangelo, Azienda Unità Sanitaria Locale Della Romagna, Arcispedale Sant'Anna, Ospedale Infermi di Rimini, Policlinico San Matteo Fondazione, Istituti di Ricovero e Cura a Carattere Scientifico, Fondazione IRCCS Istituto Nazionale dei Tumori, Azienda Ospedaliera Universitaria Pisana, University of Bologna
ORCID: 0000-0001-7287-4848
Observed ORCID: 0000-0001-7287-4848
OpenAlex ID: A5005810267
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
2019 · Giovanni Fucà, Giulia Galli, et al. · ESMO Open · 213
PDF
The ‘surprise’ question in advanced cancer patients: A prospective study among general practitioners
2014 · Matteo Moroni, Donato Zocchi, et al. · Palliative Medicine · 182
Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis
2022 · Giuseppe Viscardi, Antonino C. Tralongo, et al. · European Journal of Cancer · 159
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out
2019 · C. Proto, R. Ferrara, et al. · Cancer Treatment Reviews · 159
PDF
EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort
2019 · Arsela Prelaj, Roberto Ferrara, et al. · Cancers · 82
PDF
Acute exogenous TSH administration stimulates leptin secretion in vivo
2010 · Ferruccio Santini, Giulia Galli, et al. · European Journal of Endocrinology · 74
Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer
2019 · Giulia Galli, Tiziana Triulzi, et al. · Lung Cancer · 73
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer
2019 · Giulia Galli, Alessandro De Toma, et al. · Lung Cancer · 69
Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients
2019 · Federico Nichetti, Francesca Ligorio, et al. · Cancers · 66
PDF
Chronic sleep deprivation and seasonality: implications for the obesity epidemic.
2011 · G Cizza, M Requena, et al. · PubMed · 59
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program
2021 · Arsela Prelaj, Achille Bottiglieri, et al. · European Journal of Cancer · 58
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)
2018 · Martina Imbimbo, Margaret Ottaviano, et al. · Cancer Treatment Reviews · 57
PDF
MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review
2018 · Giuseppe Lo Russo, Anna Tessari, et al. · Frontiers in Oncology · 52
PDF
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)
2024 · C. Proto, M. Ganzinelli, et al. · Annals of Oncology · 50
PDF
Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients
2023 · Arsela Prelaj, Edoardo Gregorio Galli, et al. · Frontiers in Oncology · 48
PDF
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial
2018 · Claudio Vernieri, Diego Signorelli, et al. · Clinical Lung Cancer · 41
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors
2018 · Luigia Stefania Stucci, Stella D'Oronzo, et al. · Cancer Treatment Reviews · 41
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers
2020 · Riccardo Lobefaro, Giuseppe Viscardi, et al. · Lung Cancer · 39
No Association Between Leptin Levels and Sleep Duration or Quality in Obese Adults
2011 · Kristen L. Knutson, Giulia Galli, et al. · Obesity · 39
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines
2023 · Claudia Proto, Sara Manglaviti, et al. · Journal of Thoracic Oncology · 36
PDF
Inverse relationship of food and alcohol intake to sleep measures in obesity
2013 · G Galli, P Piaggi, et al. · Nutrition and Diabetes · 36
PDF
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy
2022 · Arsela Prelaj, Mattia Boeri, et al. · Cancers · 34
PDF
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study
2019 · Giovanni Fucà, Luigi Mariani, et al. · Scientific Reports · 32
PDF
Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
2018 · Giovanni Fucà, Giulia Galli, et al. · Targeted Oncology · 30
Clinical implications for pro-GRP in small cell lung cancer. A single center experience
2017 · Stefano Cavalieri, Daniele Morelli, et al. · The International Journal of Biological Markers · 30
PDF
Works count: 164
Citation count: 2,494
H-index: 28
I10-index: 60
Year
Topic
Type